{"doi":"10.1172/jci114723","title":"Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.","abstract":null,"journal":"Journal of Clinical Investigation","year":1990,"id":43095,"datarank":19.500540276993263,"base_score":7.023758954738443,"endowment":7.023758954738443,"self_citation_contribution":1.0535638432107666,"citation_network_contribution":18.446976433782496,"self_endowment_contribution":1.0535638432107666,"citer_contribution":18.446976433782496,"corpus_percentile":null,"corpus_rank":null,"citation_count":1122,"citer_count":200,"citers_with_citation_signal":200,"citers_with_endowment":200,"datacite_reuse_total":2,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":205317,"name":"M Hudoba","orcid":null,"position":1,"is_corresponding":false},{"id":205318,"name":"D Massel","orcid":null,"position":2,"is_corresponding":false},{"id":205319,"name":"J Maraganore","orcid":null,"position":3,"is_corresponding":false},{"id":205320,"name":"J Hirsh","orcid":null,"position":4,"is_corresponding":false},{"id":205316,"name":"J I Weitz","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":7.023758954738443,"endowment":7.023758954738443,"datacite_reuse_total":2,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"2384594","pmcid":"PMC296739","openalex_id":"https://openalex.org/W2138849164","authors":[],"funders":[],"total_grants":0,"fwci":69.045,"citation_percentile":0.99962506,"influential_citations":27,"citation_trend":[{"year":2012,"count":22},{"year":2013,"count":28},{"year":2014,"count":16},{"year":2015,"count":14},{"year":2016,"count":21},{"year":2017,"count":19},{"year":2018,"count":10},{"year":2019,"count":9},{"year":2020,"count":5},{"year":2021,"count":13},{"year":2022,"count":9},{"year":2023,"count":6},{"year":2024,"count":9},{"year":2025,"count":7},{"year":2026,"count":5}],"oa_status":"bronze","license":null,"oa_locations":[{"url":"http://www.jci.org/articles/view/114723/files/pdf","host_type":"journal"},{"url":"http://www.jci.org/articles/view/114723/files/pdf","host_type":"BRONZE"},{"url":"http://www.jci.org/articles/view/114723/files/pdf","host_type":"publisher"},{"url":"https://doi.org/10.1172/jci114723","host_type":"journal"},{"url":"http://europepmc.org/articles/PMC296739","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/296739","host_type":"repository"}],"fields_of_study":["Blood properties and coagulation","Platelet Disorders and Treatments","Blood Coagulation and Thrombosis Mechanisms","Chemistry","Medicine","Amino Acid Chloromethyl Ketones","Antithrombin III","Blood Coagulation","Fibrin","Fibrinopeptide A","Heparin","Hirudins","Humans","In Vitro Techniques","Kinetics","Peptide Fragments","Protease Inhibitors","Protein Binding","Solubility","Thrombin"],"mesh_terms":["Humans","Thrombin","Heparin","Amino Acid Chloromethyl Ketones","Fibrinopeptide A","Peptide Fragments","Fibrin","Antithrombin III","Hirudins","Protease Inhibitors","Protein Binding","Blood Coagulation","Kinetics","Solubility","In Vitro Techniques"],"keywords":["Thrombin","Antithrombin","Hirudin","Discovery and development of direct thrombin inhibitors","Chemistry","Heparin","Fibrin","Coagulation","Antithrombins","Pharmacology","Biochemistry","Internal medicine","Platelet","Medicine","Immunology"],"sdg_mappings":[],"linked_datasets":[{"doi":"10.6084/m9.figshare.14509473.v1","title":"Additional file 1 of Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14509473","title":"Additional file 1 of Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study","publisher":"figshare","resource_type":"JournalArticle"}],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-14T16:12:38.458649Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}